Loading stock data…
$8.77-0.21 (-2.34%)
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to ...